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Summary 
Insertion/deletion (IDL) mismatches in DNA are lesions 
consisting of extra bases on one strand. Here, the 
binding of ~53 and its 14 kDa D-terminal domain to 
DNAs containing one or three 3-cytosine IDL mis- 
matches was examined. Electron microscopy showed 
that both p53 forms bound predominantly as tetramers 
at the lesions while single-stranded binding proteins 
did not bind. Gel retardation assays showed that ~53 
formed highly stable complexes when the DNA con- 
tained the IDL mismatches, but only unstable com- 
plexes when the DNA lacked lesions (but did contain 
free ends). The highly stable complexes had a half-life 
of >2 hr, suggesting that upon encountering lesions, 
p53 may recruit other proteins to the site, providing 
a signal for DNA damage. 
Introduction 
Failure of the cell to recognize and repair DNA damage 
frequently provides a key early step in tumor progression, 
as recently demonstrated by the discovery of the role of 
the postreplication mismatch repair genes in hereditary 
nonpolyposis colon cancer. Here, mutations in members 
of the mutS and mutL families of proteins that repair dam- 
age resulting from a variety of causes were shown to be 
directly linked to this disease (Fishel et al., 1993; Leach 
et al., 1993; Bronner et al., 1994; Papadopoulos et al., 
1994; Nicolaideset al., 1994). The introduction of damage 
into the DNA of higher eukaryotic cells leads to many 
events, including increased activities of p53 protein (Kas- 
tan et al., 1991). This increase appears to orchestrate the 
activation of certain genes, including p21 /WAf 7 (El-Diery 
et al., 1993), GADD45 (Kastan et al., 1992), and mdm2 
(Perry et al., 1993), resulting in either growth arrest or 
apoptosis. Both the inhibition of DNA replication (Dutta et 
al., 1993) and a block at the Gl/S border (Martinez et al., 
1991) allow time for the cell to repair its DNA or, under 
different circumstances, lead to an apoptotic pathway 
(Shaw et al., 1992; Yonish-Rovach et al., 1991; Wu and 
Levine, 1994). Known classically as a tumor suppresser, 
p53 has been shown to be mutated in a large fraction of 
human tumor tissues and to be sequestered from its nor- 
mal function by specific tumor virus proteins (Linzer and 
Levine, 1979; Lane and Crawford, 1979; Sarnow et al., 
1982; Werness et al., 1990). Together, these studies re- 
veal a great deal about the role of p53 as a cell cycle 
checkpoint factor able to sense DNA damage. The precise 
link between lesions in DNA and the activation of ~53, 
however, has remained unclear. 
Biochemically, ~53 can be divided into three major do- 
mains, a charged N-terminal portion (residues l-42), a 
central domain (residues 120-290) and a C-terminal do- 
main (residues 310-390). The N-terminal region appears 
to be involved in transcriptional activation (Lin et al., 1994), 
while the central domain confers sequence-specific DNA 
binding (Wang et al., 1993a, 1994a; Pavletich et al., 1993; 
Bargonetti et al., 1993). Most of the mutants of ~53 in 
human tumors map to this central region. The C-terminal 
domain contains residues that confer on p53 the ability to 
oligomerize and to bind both single-stranded DNA 
(ssDNA) and RNA(Pavletich etal., 1993; Cloreet al., 1994; 
Wu et al., 1995). 
The ability of ~53 to bind to ends and single-stranded 
gaps in DNA has led to the suggestion that it may directly 
recognize damaged DNA since these structures fre- 
quently accompany exposure to irradiation or some muta- 
gens. Further, electroporation of nucleases into cells has 
been shown to lead to increased levels of ~53 (Nelson 
and Kastan, 1994). Many proteins, however, bind nonspe- 
cifically to ssDNA or to DNA ends, e.g., the yeast TATA- 
binding protein (Griffith et al., 1995). The placement of 
p53 on a pathway involving signaling of damaged DNA 
has been strengthened by the discovery that GADD45, 
which is induced by ~53, interacts with the proliferating 
cell nuclear antigen, one of the proteins directly involved 
in DNA replication and repair (Smith et al., 1994) and that 
is found associated with ERCC3, a transcription factor 
involved in nucleotide excision repair (Wang et al., 1994b), 
and with replication protein A (RPA), a factor central to 
DNA replication and repair (Dutta et al,, 1993). Indeed, 
both RPA and ERCC3 are part of a multifactor complex 
involved in human excision repair (reviewed by Sancar, 
1994). 
It is possible that the induction of ~53 following irradia- 
tion and carcinogen exposure could reflect a response to 
both the initial lesions (e.g., thymine dimers and psoralen 
cross-links) and damage such as single base and inser- 
tion/deletion (IDL) mismatches (the latter also termed 
bulged or extra bases). IDL mismatches represent lesions 
in which there is one or more extra base on one strand 
of the DNA than on the other and can be either the result 
of polymerase-induced errors during replication or a sec- 
ondary consequence of insult by irradiation or carcino- 
gens. When lesions such as thymine dimers are intro- 
duced into DNA, translesion synthesis may insert a 
nucleotide(s) opposite the noninformational site, and this 
could leave behind mispairs and bulges (see Spivak and 
Hanawalt, 1992). Single base and IDL mismatches are 
repaired by the mutHLS system in Escherichia coli (Mo- 
drich, 1991; Parker and Marinus, 1992) and an analogous 
system in yeast and higher eukaryotic cells (reviewed by 
Kolodner and Alani, 1994), with mutS and its eukaryotic 
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CGAACCCGTrCTCGGAGCACTGCAGAACCGCTCi-GG CCG CCGCCCAGCC 3' 
3,CCGAGC'FrGGGCAAGAGCCTCGTGACGTCTTGG CGAAACCGGCGGCGGG 
3G/T 
CGAACCCGTTCTCGGAGCACTGTAGAGCCGTTTTGGCCGCCGCCCAGCC 
3,CCGAGCTrGGGC,~&GAGCCTCGTGACGTCTTGGCG~ACCGGCGGCGGG 
Figure 1. Sequence of the DNA Cassettes Used to Construct 1.1 kb 
Lesion-Containing DNAs 
The location of one 3-cytosine (C3) or three 3-cytosine (3 C3) inserts 
on the top strand of the 45 bp DNA is illustrated as well as the loci of 
three G/T mismatches (3 G/T). 
homologs MSH1 and MSH2 providing primary recognition 
of the lesions. Studying yeast, Kolodner and colleagues 
(Bishop and Kolodner, 1986; Muster-Nassal and Kolodner, 
1986; Reenan and Kolodner, 1992) provided direct evi- 
dence both in vivo and in vitro of repair of single base and 
IDL mispairs in a PMS1- and MSH2-dependent fashion. 
Sites containing single base mismatches and single base 
IDL mismatches are also cleaved, although inefficently, 
by the human excision repair system (Huang et al., 1994), 
illustrating the fact that there is likely overlap in lesion 
recognition by the different repair systems. Another E. coli 
protein, recA, also binds to DNA containing IDL mis- 
matches and some single base mismatches (Wang et al., 
1993b). Indeed, a number of loose analogies can be drawn 
between p53 and recA. Both proteins catalyze the rean- 
nealing of complementary ssDNA (Cox and Lehman, 
1981; Oberosler et al., 1993; Wu et al., 1995), and p53 
has been reported to catalyze strand transfer (Bakalkin et 
al., 1994), a classic recA function. Further, irradiation of 
E. coli cells leads to the "activation" of recA and induction 
of the SOS response, making recA the key control element 
of a simple bacterial DNA damage signaling pathway. The 
knowledge that recA directly recognizes IDL mismatches 
led us to ask whether p53 might also bind to such lesions 
in DNA. 
In this report we present evidence from electron micros- 
copy (EM) and gel retardation studies showing that both 
p53 and its 14 kDa C-terminal domain recognize and bind 
tightly to IDL mismatches, in both cases predominantly 
as tetramers. The complexes formed at the lesions are 
highly stable, unlike complexes formed with DNA con- 
taining only free ends. Several functions for such highly 
stable complexes are discussed. 
Results 
Visualization of p53 Binding to DNA 
Containing IDL Mismatches 
DNAs 1.1 kb in length with central lesions were con- 
structed to probe the binding of p53 to single base or IDL 
mismatches. DNA cassettes 45 bp long containing 4-base 
AGCC 3' overhangs were synthesized and mixed with a 
538 bp DNA fragment containing one blunt end and one 
end with a GGCT 3' overhang resulting from Banll cleav- 
age. Under conditions inhibiting blunt-ended joining, the 
only ligation product was a 1129 bp DNA consisting of a 
single central cassette flanked by two 538 bp arms (see 
Experimental Procedures). This strategy takes advantage 
of the nonsymmetric cleavage sequence of Banil. The cas- 
settes contained no lesion, three G/I" mismatches paced 
by 3 bp, a 3-cytosine bulge in the top strand, or three such 
3-cytosine bulges, spaced by 3 bp (Figure 1). Design of 
the triple lesions was based on the work of Alani et al. 
(1995) showing that such defects provide strong recogni- 
tion signals for yeast MSH2. The three 3-cytosine bulges 
were chosen based on data from filter binding (data not 
shown) indicating that cytosine bulges provided stronger 
signals than adenine bulges. 
Human p53 (produced in insect cells) was incubated 
with the 1.1 kb DNA for 30 min at room temperature fol- 
lowed by fixation with 0.6% (p53) or 0.001% (C-terminal 
domain) glutaraldehyde. The samples were filtered through 
Biogel A5M to remove the free protein and fixatives and 
were prepared for EM by a method involving air-drying 
and rotary shadowcasting with tungsten (see Experimental 
Procedures). The incubations contained p53 or the C-ter- 
minal fragment at molar ratios varying from three to five 
protein tetramers per DNA. 
When we examined fields of complexes formed between 
p53 and the 1.1 kb DNA containing either a 3-cytosine IDL 
mismatch or three such mismatches at the center, large 
numbers of DNAs were found to be present with an easily 
observed, centrally located protein complex (Figure 2). By 
scoring fields of molecules (from an incubation with three 
tetramers per DNA that contained three IDL mismatches), 
we observed that 22% contained a protein complex bound 
at the exact center of the DNA, 58% of the DNA appeared 
protein free, 12% contained a protein complex at one or 
both ends, and 8% contained a protein complex internal 
to an end but not at the center (n = 200). When the DNA 
contained a single 3-cytosine IDL mismatch, the fraction 
of DNA molecules with p53 bound at the center was 14%, 
as contrasted with 22%. Frequently, the DNA appeared 
highly bent about the p53 complex; however, since a 
3-base IDL mismatch will bend DNA by nearly 90 ° (Wang 
et al., 1992), the lesion itself likely contributed significantly 
to the bending. Indeed, inspection of the DNA with one 
or three 3-cytosine IDL mismatches in the absence of p53 
showed that nearly half were highly kinked at the center. 
Nonetheless, p53 may contribute to the bending since 
analysis of the bending of the MCK promoter showed that 
p53 tetramers bent the DNA by up to 75 ° (S. L. and J. G., 
unpublished ata). 
When the 1.1 kb DNA containing three G/T mismatches 
spaced by 3 bp was incubated with p53 as described above 
and was examined by EM, no significant binding to the 
site of the mismatches was observed. However, G/T mis- 
matches are not recognized by recA protein (Wang et al., 
1993b), and mutS protein recognizes some single base 
mismatches much more efficiently than others (Modrich, 
1991); thus, it cannot be concluded from this single obser- 
vation that p53 does not in general recognize single base 
mismatches. 
The protein complexes bound at the site of the IDL mis- 
match fell into three size groups. The first (shown in Figure 
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Figure 2. Visualization ofp53 Bound to DNA 
Containing IDL Mismatches 
Human p53 was incubated with a 1129 bp DNA 
containing either one or three 3-cytosine IDL 
mismatches at the center. The complexes were 
prepared for EM by mounting them onto thin 
carbon foils, air-drying, and rotary shadowcast- 
ing with tungsten (see Experimental Proce- 
dures). Presumptive p53 dimers (a), tetramers 
(b-d), and higher oligomers (e) are at the site 
of the lesion. An end-bound complex is shown 
in (f). These images are shown in reverse con- 
trast. Insets how the protein complex at higher 
magnification. The scale bar equals 0.1 p_m 
(lower magnifications). 
2a) consisted of roughly spherical particles whose size 
was only marginally larger than tetramers of E. coli SSB 
(for single-strand binding) protein (76 kDa) prepared and 
shadowcast at the same time on separate grids. These p53 
particles were most likely dimers, but may have included 
some monomers. The second class of particles that were 
the most abundant (Figures 2b-2d) were significantly 
larger than the SSB tetramers and had a distinct square- 
shaped projection, and often one could distinguish three 
or four subdomains. These particles were most certainly 
p53 tetramers. Finally, larger elongated particles or short 
filaments (Figure 2e) were present that must consist of 
several p53 tetramers. In scoring p53 complexes bound 
at the site of the lesion, we found that 29% of the DNA 
was scored as containing p53 monomers or dimers, 35% 
contained p53 tetramers, and 36% had higher oligomers 
of bound p53 (n = 228). p53 was also observed bound 
to DNA ends (Figure 21'). Occasionally, circles were noted, 
generated either by p53 binding to the ends of a linear 
DNA and then interacting with itself or possibly by a single 
complex at one end capturing a second free DNA end. 
Visualization of the 14 kDa p53 C-Terminal Domain 
Binding to DNA Containing IDL Mismatches 
The 14 kDa p53 C-terminal fragment (residues 311-393; 
see Experimental Procedures) was incubated with the IDL 
mismatch-containing DNAs, as described above, and pre- 
pared for EM using three to five protein tetramers per DNA 
fragment. Examination of fields of DNAs revealed a large 
fraction with a protein complex at its center (Figure 3). 
Here, the protein complexes were much smaller than 
those observed with full-length p53. Using these EM meth- 
ods, a protein with a mass of 14 kDa would not be expected 
to be visibly bound to DNA, a protein of 28 kDa would be 
at the edge of detection, as shown recently in a study of 
the 28 kDa yeast TATA-binding protein (Griffith et al., 
1995), and a 56 kDa protein would be small but easily 
observed. Thus, the predominant C-terminal complexes 
are likely tetramers, and indeed some appeared tetrameric 
(insets in Figures 3c and 3d). When E. coli SSB tetramers 
(76 kDa) were added to the C-terminal complexes and the 
projected area of the complex compared with that of SSB 
tetramers in the background, the C-terminal complexes 
had an average area of 0.86 times that of the SSB tetra- 
mers. Conversion from an area to a volume ratio (multipli- 
cation by a power of 3•2) and multiplication by the mass of 
the SSB tetramer evealed that the C-terminal fragment- 
DNA complexes had a mass of 60 _ 17 kDa (n = 13), 
supporting the idea that these complexes were tetramers. 
When fields of molecules were scored in which the C-ter- 
minal fragment was incubated at a molar ratio of three 
protein tetramers per DNA fragment (containing three 
3-cytosine IDL mismatches), 37% had a protein complex 
at the center of the DNA, 50% of the DNA showed no 
visibly bound protein, 7% had a protein complex at one 
or both ends, and 6% of the DNA had a single protein 
complex bound internally but not at the center (n = 200). 
Only a few percent of the moleculeswith a protein complex 
at the lesion also showed protein bound either at an end 
or elsewhere on the DNA. 
The C-terminal domain of p53 confers the ability to an- 
neal ssDNA (Wu et al., 1995). One explanation for the 
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Figure 3. Visualization of the 14 kDa p53 
C-Terminal Fragment Bound to the Site of an 
IDL Mismatch 
Complexes were formed between the p53 
C-terminal fragment (residues 311-393) and 
the 1129 bp DNA containing three 3-cytosine 
IDL mismatches at the center and were pre- 
pared for EM as described in Figure 2. Insets 
show the protein complex at higher magnifica- 
tion. The scale bar equals 0.1 I~m (lower magni- 
fications). 
results described above is that p53 and its C-terminal frag- 
ment are merely recognizing single-stranded character in 
these lesions. If so, then classic single-stranded binding 
proteins that have very high affinity for ssDNA, such as 
SSB, T4 gene 32 protein, or yeast RPA, should show an 
even higher binding than p53. To examine this, we incu- 
bated the IDL mismatch-containing DNAs with each pro- 
tein at a molar ratio of 20 or 12 protein monomers per DNA 
fragment (containing either one or three IDL mismatches, 
respectively). Fields of molecules were scored for the frac- 
tion of DNA with a protein complex at the center. The 
results (Figure 4) show that while a large fraction of the 
lesions were targeted by p53 or its C-terminal domain, 
only a low background level of binding was observed with 
SSB, g32p, or yeast RPA, and most of these proteins 
showed binding to the DNA ends and not internally. Thus, 
p53 is recognizing a more subtle feature of these lesions 
than single-stranded character. Indeed, as noted in filter 
binding studies (data not shown), p53 bound better to 
3-base than 4-base cytosine bulges, yet the extra bases 
would be expected to be more exposed in the 4-base than 
the 3-base bulge. 
Gel Retardation Analysis of the Binding of p53 
and Its C-Terminal Domain to DNA 
Containing IDL Mismatches 
Gel retardation assays were utilized to obtain an indepen- 
dent quantitative measure of p53 and its C-terminal frag- 
ment binding to DNA containing IDL mismatches. Here, 
DNAs 49 bp long were synthesized with the same se- 
quences as those shown in Figure 1, but with flush ends. 
The DNA was labeled with 32p, and 1 ng was incubated with 
increasing amounts of p53 (see Experimental Procedures) 
for 20 min at room temperature and then electrophoresed 
on polyacrylamide gels. When the DNA contained no le- 
sion, faint retarded bands due to the formation of a p53- 
DNA complex could be seen with the higher levels of p53 
(Figure 5A, lanes 3 and 4). When the DNA contained either 
one or three 3-cytosine bulges (Figure 5A, lanes 5-12), a 
very distinct series of retarded bands was observed even 
with the lowest amount of p53 added in the incubations. 
Based on EM observations, we assume that this distinct 
series of bands includes p53 bound to DNA ends and p53 
monomers, dimers, tetramers, and possibly higher oligo- 
mers bound at the lesion. Quantiation of the amount of 
DNA in the retarded lanes (Figure 5B) showed that with 
24 nM p53, 40% of the total lesion-containing DNA was 
retarded, while less than 5% was retarded with the lesion- 
free DNA. To determine whether the C-terminal fragment 
would show binding in these assays, we incubated the 
same DNAs with full-length p53 (Figure 5C, lanes 4-6) or 
with the 14 kDa C-terminal fragment (lanes 7-9). As shown 
in Figure 5, retarded bands were observed with both le- 
sion-containing DNAs and with both p53 forms, with the 
mobility of the retarded bands being higher with the C-ter- 
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Figure 4. Classic ssDNA-Binding Proteins Do Not Recognize IDL Mis- 
matches 
Three proteins with high affinity for ssDNA (E. coil SSB, T4 gene 32 
protein, and yeast RPA) were incubated with the 1.1 kb DNAs con- 
taining either one 3-cytosine IDL mismatch (~3) or three such mis- 
matches (3-C3) and prepared for EM as described in Figure 2. Fields 
of molecules were scored for the fraction containing a protein complex 
at the lesion. Molar atios of 20 and 12 protein monomers per DNA were 
used for the one 3-cytosine IDL mismatch and the three 3-cytosine IDL 
mismatch DNAs, respectively. 
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Figure 5. Gel Shift Analysis of the Binding of p53 to DNA Containing 
IDL Mismatches 
(A) Gel shift analysis of p53 binding to a 32P-labeled 49 bp DNA (3 nM) 
containing no lesion (lanes 1-4), a single 3-cytosine bulge (lanes 
5-8), or three 3-cytosine bulges (lanes 9-12) was carried out by incu- 
bating the DNAs with no p53 (lanes 1, 5, and 9), 6 nM p53 (lanes 2, 
6, and 10), 12 nM p53 (lanes 3, 7, and 11), or 24 nM p53 (lanes 4, 8, 
and 12) for 20 min at room temperature, followed by electrophoresis 
on polyacrylamide gels (see Experimental Procedures). 
(B) The fraction of DNA shifted in each band in (A) was quantitated: 
no p53 (Con), one 3-cytosine bulge (C3), or three 3-cytosine bulges 
(3C3). 
(C) The DNA lacking the lesion (lanes 1, 4, and 7), with a 3-cytosine 
bulge (lanes 2, 5, and 8), or with three 3-cytosine bulges (lanes 3, 6, 
and 9) was incubated with no p53 (lanes 1-3), with full-length p53 
(lanes 4-6), or with the 14 kDa C-terminal fragment (lanes 7-9). 
minal fragment as expected. Here, two shifted bands were 
observed that may correspond to dimers and tetramers 
or the C-terminal fragment bound to the lesion. 
Gel retardation assays coupled with the addition of com- 
petitor DNA provide a means of examining the stability 
of DNA-protein complexes• Here, the radiolabeled DNAs 
described above were incubated with p53 (Figure 5A; 1 
ng of DNA; 25 ng of p53) at room temperature for 20 min, 
followed by the addition of increasing amounts of unla- 
beled DNA for an additional 20 min. The sample was then 
electrophoresed on polyacrylamide gels, the position of 
the radiolabeled DNA determined by phosophorimaging, 
and the amount of DNA in each band determined (see 
Experimental Procedures). As shown in Figures 6A and 
3C 3 
cs 
100 ZOO 
COMPETITOR DNA t ry)  
3~o 
123456 789  101112 
Figure 6. Gel Shift Competition Analysis of the Stability of p53 Bound 
to IDL Mismatches 
(A) 3~P-labeled 49 bp DNAs (1 ng) containing no lesion (lanes 1-4), 
one 3-cytosine bulge (lanes 5-8), or three 3-cytosine bulges (lanes 
9-12) were incubated with 12 nM p53 for 20 min at room temperature, 
and then increasing amounts of the same sequence DNA (lacking 
lesions and not labeled) were added for an additional 20 min before 
electrophoresis on polyacrylamide gels. Amounts of added competitor 
were 0 ng (lanes 1,5, and g), 50 ng (lanes 2, 6, and 10), 100 ng (lanes 
3, 7, and 11), or 200 ng (lanes 4, 8, and 12). 
(B) The amount of total DNA shifted into the retarded bands was mea- 
sured and plotted• A clear biphasic response to challenge by the com- 
petitor is seen for the DNA with one 3-cytosine bulge (C3) or three 
3-cytosine bulges (3C3), but not for the DNA lacking the bulges (Con)• 
(C) The experiment in (A) was repeated using 75 ng of cold competitor 
DNA, but the time of incubation with the competitor varied from 0 min 
(lanes 1-3), 20 min (lanes 4-6), and 120 rain (lanes 7-9) to 17 hr (lanes 
10-12). The DNAs contained no lesion (lanes 1, 4, 7, and 10), one 
3-cytosine bulge (lanes 2, 5, 8, and 11), or three 3-cytosine bulges 
(lanes 3, 6, 9, and 12). 
6B, while none of the complexes formed on the DNA lack- 
ing lesions was resistant to the added competitor, -45% 
and - 40% of the complexes with three and one 3-cytosine 
bulges, respectively, were resistant to a 200-fold excess 
of competitor DNA. To examine further the stability of 
these complexes, incubations as shown in Figure 6A, us- 
ing the DNA with three 3-cytosine bulges (and 75 ng of 
competitor) and four incubation times in the presence of 
Cell 
1018 
competitor (0 min, 20 min, 120 min, and 17 hr), were tested. 
As shown in Figure 6C, in agreement with the previous 
experiment, roughly half of the complexes decayed rap- 
idly, but then little change was seen between 20 min and 
120 min, and the complexes disappeared only after a 17 
hr incubation. This suggests that the stable complexes 
have a half-life of >2 hr, and similarities with work on MSH2 
are discussed below. 
Discussion 
The experiments presented here demonstrate that p53 
and its C-terminal domain recognize sites on DNA con- 
taining IDL mismatches, a common form of primary DNA 
damage. Excellent concordance of the results obtained 
by two very different methods, EM and gel retardation, 
was observed, and our EM observations are in general 
agreement with those of Stenger et al. (1994), who exam- 
ined p53 binding to a p53 response element by EM and 
observed p53 tetramers bound to DNA. In our EM studies, 
p53 and its C-terminal domain were seen to bind selec- 
tively to a site containing one or three 3-cytosine IDL mis- 
matches in a 1.1 kb DNA, binding predominantly as protein 
tetramers. EM showed that these lesions were not recog- 
nized by the classic ssDNA-binding proteins, allowing us to 
argue that p53 detected the lesion and not single-stranded 
character. Gel retardation assays in which increasing 
amounts of competitor DNA were added revealed that two 
types of complexes were formed on the DNA: unstable 
ones that were also seen with DNAs lacking lesions but 
containing free ends, and highly stable complexes that 
required the presence of an IDL mismatch. 
Support for the biological relevance of in vitro studies 
characterizing proteins that bind mispairs and IDL mis- 
matches comes from work in yeast, where it has been 
shown that the substrate specificity in vitro for MSH1 and 
MSH2 parallels the repair efficiency in vivo (Bishop and 
Kolodner, 1986; Chi and Kolodner, 1994; Alani et al., 1994; 
for detailed review see Alani et al., 1995). Indeed, it is 
instructive to compare our results with studies of MSH2 
by Fishelet al. (1994) and Alani et al. (1995). There, using 
gel retardation and filter binding assays, it has been ob- 
served that yeast and human MSH2 shows only a modest 
selectivity for mispaired bases but has a high affinity for 
IDL mismatches, with the affinityincreasing asthe number 
of extra bases in the bulge increases. In the work of Alani et 
al. (1995), two kinds of complexes were detected: unstable 
complexes formed when MSH2 bound to homoduplex 
DNA, and highly stable ones formed when the latter com- 
plex encountered mismatched bases. The stable com- 
plexes were resistant o challenge by excess competitor, 
leading Alani et al. (1995) to propose that MSH2 under- 
goes a conformational change when it forms a stable com- 
plex at the lesion. They further suggest that the stable 
complex serves as a recognition signal for interaction with 
proteins involved in subsequent steps. Here, we observed 
only background binding of p53 at the site of a G/T mis- 
match, strong binding to a 3-base bulge, even stronger 
binding with three closely spaced bulges, and stronger 
binding yet to a single bulge containing four CA repeats 
(data not shown). Further, when p53 was incubated with 
DNA lacking lesions, binding was rapidly eliminated by the 
addition of competitor DNA, but when the DNAs contained 
bulges, 40%-45% of the complexes resisted challenge 
by a 200-fold excess of competitor, arguing for the pres- 
ence of unstable and highly stable complexes like those 
seen with MSH2. Finally, using similar approaches to 
those of Alani et al. (1995), who reported a half-life of at 
least 8 hr for the stable MSH2 complexes, we observed 
that the stable p53 complexes had a half-life of at least 2 
hr and possbily considerably more. Based on these com- 
parisons, we would suggest that, like MSH2, p53 forms 
initially unstable complexes that then become highly sta- 
ble complexes upon encountering IDL misrn'atches. 
The formation of highly stable complexes on DNA could 
reflect, among other things, a higher inherent affinity for 
deformations or lesions in DNA than for DNA ends or, as 
suggested by Alani et al. (1995) for MSH2, a conforma- 
tional change in the protein that occurs upon binding to 
the lesion. Our present data do not allow us to distinguish 
among the several possibilities. However, the finding that 
lesion binding is mediated by the C-terminal domain, com- 
bined with the work of others (Hupp et al., 1992; Bayle et 
al., 1995) that showed that the C-terminal domain also 
regulates binding of the central domain, suggests that the 
C-terminal and central domains communicate to facilitate 
DNA binding. This is supported by the observation that 
binding of duplex DNA at the C-terminal domain signifi- 
cantly reduces the ability of the central domain of p53 to 
bind to sequence-specific sites inDNA (Bayle et al,, 1995). 
Further, L. Jayaraman and C. Prives (personal communi- 
cation) recently observed that short (but not long) ssDNA 
fragments of the size removed by the human excision re- 
pair system stimulate the ability of p53 to bind to the 
GADD45 response element in supertwisted DNA. Finally, 
based on their recent X-ray structure of the p53 tetrameri- 
zation domain, Jeffrey et al. (1995) raised the possibility 
that the C-terminal portion of p53 could modulate the se- 
quence-specific binding activity. 
There are numerous biological ramifications for very sta- 
ble p53 complexes formed at lesions in DNA. The half-life 
of p53 in vivo is short owing to rapid protease degradation 
(Chowdary et al., 1994). Following irradiation or exposure 
to mutagens, p53 shows an accumulation in the nucleus 
and increased activity owing, it is believed, to an increased 
half-life (Kastan et al., 1991; Nelson and Kastan, 1994; 
Price and Calderwood, 1993; Tishler et al., 1993), likely 
reflecting an increase in protease resistance. This might 
occur if, upon binding DNA at the site of a lesion, a confor- 
mational change were to hide protease sensitive sites. A 
highly stable p53 complex at the site of a lesion could 
provide a scaffold for the assembly of multiprotein com- 
plexes engaged in DNA repair and could enhance the abil- 
ity of p53 to activate specific genes involved in cell cycle 
control, apoptosis, or DNA damageresponse. 
Experimental Procedures 
DNA Templates 
Oligonucleotides of 49 bases were synthesized on an Applied Biosys- 
terns 380B DNA synthesizer, deprotected, purified on 12% urea gels, 
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annealed to produce the 45 bp cassettes with 4 nt 3' overhangs, and 
finally electrophoresed on 10% nondenaturing polyacrylamide gels to 
remove any ssDNA. The duplex arms were prepared by PCR amplifica- 
tion (Perkin-Elmer thermocycler) using primers that amplified a 640 
bp segment in pBR322 DNA containing a single Banll site. This DNA 
was digested with Banll endonuclease, and the 538 bp fragment con- 
taining one blunt end and one end with a GGCT 3' overhang was 
separated by electrophoresis on a 1.2% agarose gel. The 538 bp DNA 
arms were ligated to the 45 bp cassettes (Figure 1 ) at room temperature 
for 2 hr. The final product (1129 bp) was purified from 1.2% aga- 
rose gels. 
For gel retardation assays, 49 bp duplexes containing either no 
mismatch, a single 3-cytosine bulge at the center, or three such bulges 
at the center were prepared by annealing 49 nt oligonucleotides syn- 
thesized as above to produce duplex DNAs with blunt ends. 
Proteins 
p53 protein and the C-terminal fragment were purified as described 
by Wu et al. (1995). E. coil SSB protein was prepared as described 
by Chase et al. (1980). T4 phage gene 32 protein was the gift of W. 
Konigsberg (Yale University). Yeast RPA protein was the gift of R. 
Kolodner (Harvard University). Restriction endonucleases, T4 DNA 
ligase, and T4 DNA kinase were from New England Biolabs and were 
used according to the specifications of the manufacturer. 
EM 
Complexes of p53 or its C-terminal fragment and DNA were formed 
by incubating 100 ng of DNA in 50 p.I of 10 mM HEPES (pH 7.5), 100 
mM NaCI buffer for 20 min at room temperature using the amounts 
of protein indicated in the text. The DNA-protein complexes were then 
prepared for EM by fixation with 0.6°/0 (p53) or 0.001o/0 (C-terminal 
fragment) glutaraldehyde for 10 min at room temperature, followed by 
filtration through 2 ml columns of Biogel A5M (Bio-Rad). The filtered 
samples were mixed with a buffer containing 2 mM spermidine, 0.15 
M NaCI and applied for 30 s to thin carbon foils supported by 400 
mesh copper grids. The grids were washed with sequential washes 
of water and graded ethanol series, air-dried, and rotary shadowcast 
at 10 .7 torr with tungsten (Griffith and Christiansen, 1978). Samples 
were examined in a Philips CM12. To estimate the mass of DNA- 
protein complexes, we measured the projected areas of images on 
35 mm film using a Sony CCD camera and the NIH IMAGE software. 
Gel Retardation Assays 
For gel retardation assays, blunt-ended 49 bp DNA duplexes (Figure 1; 
DNA templates as described above) purified from 100/0 nondenaturing 
polyacrylamide gels were labeled with [32P]rATP using T4 DNA kinase 
and then passed through G50 spin columns. Details of amounts of 
DNA, incubation temperature, and time appear in the text and figure 
legends. Amounts of DNA based on adding the same amount of radio- 
activity were mixed with loading dye and electrophoresed on 3.5% 
polyacrylamide gels (19:1 acrylamide:bisacrylamide) at 200-300 V at 
room temperature in 0.5x TBE buffer until the unbound DNAs mi- 
grated close to the bottom of the gel. The position of the DNA was 
visualized by a Molecular Dynamics phosphorimager. Binding buffer 
for the gel shift experiments with the C-terminal fragment was the 
same as in the EM studies, but with full-length p53, a buffer containing 
100 mM NaCI, 10 mM HEPES (pH 7.5), 10% glycerol, 100 p.g/ml BSA, 
0.5 mM DTT, and 0.025% NP-40 was utilized to aid in stabilizing p53 
at the low protein concentrations. The protein was stored at -70°C, 
and freezing and thawing were avoided as much as possible. 
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